President Donald Trump’s Choosing to lead the Food and Drug Administration (FDA) shifted the issue of the vaccine process to a Democratic senator during a confirmation hearing on Thursday, suggesting that they ask former President Joe Biden why he skipped a key step in Covid-19-19-19-19-Booster.
Dr. Marty Makarya professor at Johns Hopkins Medical School and a former Fox News medical contributor, Senate Health, Education, Labor and Pension (Help) before he answered questions about vaccines, chronic diseases, food safety and abortion.
“So if you get confirmed, will you immediately reschedule the FDA Vaccine Advisory Committee meeting to express the opinions of experts?” Senator Patty Murray, d-wash. Ask Trump’s FDA draft pick.
In Elon Musk’s Miscellaneous with Republican Senators: Save $4 million a day
Dr. Marty Makary pointed out that when the Biden administration authorized the vaccine, it decided to skip the key committee meeting in response to the questions of senior Democratic people. (Reuters)
Her question is about the FDA Vaccine Conference It is said that Postponed at the last minute.
“I will reevaluate which topics should be convened by members of the Advisory Committee [Vaccines and Related Biological Products Advisory Committee] Makary replied that this might not require a call, pointing out that he was not part of the decision.
FDA Commissioner nominee Murray asked again: “Well, you can ask the Biden administration to choose not to convene a committee meeting to boost the booster vaccine booster.”
President Joe Biden received the No. 19 Booster in the Southern Court Auditorium at the White House on October 25, 2022. (Tom Brenner via Getty Images in The Washington Post)
In 2021, Biden’s administration clearly passed FDA approval to provide boosters for everyone over the age of 18. One conclusion is that these requests will not raise additional issues discussed by committee members. ”
At that time, the committee member Dr. Paul Offit“We were asked to approve this was a three-dose vaccine for people aged 16 and older, and there was no clear evidence if the third dose of young people is valuable compared to the older people,” said the director of the Center for Vaccine Education at Children’s Hospital in Philadelphia.
House Gopers hopes Trump is opening up mineral deal for Ukraine despite Oval Office dispute
On August 29, 2020, the Food and Drug Administration is headquartered in White Oak, Maryland. (Reuters/Andrew Kelly/Archive Photo)
Fox News Digital asked Murray if he was also concerned about Biden’s decision. “In 2022, I believe our public health agencies are following the latest science and listening to public health experts. I don’t have that kind of confidence right now,” the senator said in a statement.
“We are talking about Trump and the small RFK Jr. canceled a regular meeting that was held for at least 30 years a year to make recommendations that influenza vaccines should include influenza strains in the upcoming flu season – to cancel their cancellation or when they will be revoked, please proceed.” “The flu vaccine is safe, effective and life-saving – we need this advisory committee to meet so that manufacturers have enough time to prepare the right vaccine.”
Before Thursday’s hearing, Murray and his fellow countrymen helped Democratic Wisconsin’s Tammy Baldwin and Maryland’s Angela Alsobrooks write a letter to Makary, telling him: “We intend to use your nomination hearing next week to see if you support this insignificant measure to slow critical public health decisions.”
Republican rebels fire warning shot in shutdown showdown: No, no deal
Cassidy is the chairman of the Help Committee. (Ting Shen/Bloomberg via Getty Images)
Help Chairman Bill Cassidy, R-La. Also asked about postponing the meeting, Makary asked: “How will you ensure that the advisory committee remains objective, transparent and still benefit from the necessary expertise of external experts?”
Click here to get the Fox News app
The nominee told Cassidy: “You promise to review what the board is doing [and] How they are used. ”
“As you know, I’m vital when the committee was not convened at all in one of the FDA’s Covid Booster guidance decisions,” Makary noted.
He recalled that the FDA leadership “at the time to argue that they were consultants and we didn’t have to call them up. It was repeated throughout the Biden administration.”
